Name the Fear and It Shrinks — On the Amygdala
Becoming the chairman of a listed company does not remove anxiety. Because it does not, I learned how to handle it. Neuroscience reports that attaching verbal labels to emotion is accompanied by reduced activity in the amygdala, the region tied to fear and anxiety — a phenomenon called affect labeling.
A brain in vague dread is less settled than one that can say, "right now I am afraid about cash flow." The reason is easy to imagine: nameless anxiety has no outline and is therefore infinite, while the moment it is named it becomes a finite problem — and finite problems can be worked on.
So the more anxious I am, the more I write: what am I afraid of, what is the worst case, and what would I do if the worst actually happened. By the third line the monster has turned into a task. The greatest danger in management is not the bad situation itself but carrying a bad situation without putting it into words.
What anxiety of yours is still unnamed?
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
Next Essay
Meaning Over Reward — The Research on Intrinsic Motivation
Read →About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.